Skip to Main Content

Author Details

Michael Xiang
University of California los angeles
2007
52
18
PMIDPaper TitleJournal TitlePublished Year
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
36966268Race-dependent association of clinical trial participation with improved outcomes for high-risk prostate cancer patients treated in the modern era.Prostate Cancer Prostatic Dis2023
36923158Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib.JTO Clin Res Rep2023
36870853Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.Eur Urol Oncol2023
36896266Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT).Clin Transl Radiat Oncol2023
36863416Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.Int J Radiat Oncol Biol Phys2023
34866018Trends and Predictors of Hypofractionated and Intensity-Modulated Radiotherapy for Organ Preservation in Bladder Cancer.Clin Genitourin Cancer2022
35700225Accurate Identification of Transcription Regulatory Sequences and Genes in Coronaviruses.Mol Biol Evol2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35521072Prostate-Centric Versus Bony-Centric Registration in the Definitive Treatment of Node-Positive Prostate Cancer with Simultaneous Integrated Boost: A Dosimetric Comparison.Adv Radiat Oncol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
36228003CNAViz: An interactive webtool for user-guided segmentation of tumor DNA sequencing data.PLoS Comput Biol2022
36094506Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer.JAMA Netw Open2022
35033605Landscape of mortality during and within thirty days after non-palliative radiotherapy across eleven major cancer types.Radiother Oncol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
33383061Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors.Radiother Oncol2021
33781714Role of brachytherapy in stage III endometrial cancer treated with adjuvant chemotherapy: Identifying factors predictive of a survival benefit.Brachytherapy2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
33373063Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses.Am J Hematol2021
33417322Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.Am J Clin Oncol2021
31230228Survival after neoadjuvant approaches to gastroesophageal junction cancer.Gastric Cancer2020
32044168Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.Radiother Oncol2020
31765941CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.Neoplasia2020
31912686Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.J Gynecol Oncol2020
33312677Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.Neurooncol Pract2020
33071215<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition.Cancer Discov2020
32429982Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume.Radiat Oncol2020
32426866Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy.Cancer2020
30551884National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.Gynecol Oncol2019
31856268Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.Blood Adv2019
31487677Survival After Definitive Chemoradiotherapy With Concurrent Cisplatin or Carboplatin for Head and Neck Cancer.J Natl Compr Canc Netw2019
31257010Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.Gynecol Oncol2019
31390586Benefit of Cisplatin With Definitive Radiotherapy in Older Women With Cervical Cancer.J Natl Compr Canc Netw2019
30925635Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis.Breast J2019
31067077Physiological motion of the optic chiasm and its impact on stereotactic radiosurgery dose.Br J Radiol2019
31009783Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.World Neurosurg2019
30332498Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.Cancer2018
26985191Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.J Contemp Brachytherapy2016
27531676Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.Blood2016
24662818The transcriptional modulator BCL6 as a molecular target for breast cancer therapy.Oncogene2015
26489921Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.Brachytherapy2015
23531638Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer.Mol Cell Endocrinol2014
24762632STAT3 Activity and Function in Cancer: Modulation by STAT5 and miR-146b.Cancers (Basel)2014
24435449Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.Mol Cancer Ther2014
24473196STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.Sci Signal2014
23264850The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations.Genes Cancer2012
24058751STAT signaling in the pathogenesis and treatment of myeloid malignancies.JAKSTAT2012
20139945Ontology engineering.Nat Biotechnol2010
20215353Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.Development2010
  • 1 - 50 of 52

Recommended Authors

Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2017
Number of shared co-authors 21
Hilary P Bagshaw
Stanford University
Career Start Year 2014
Number of shared co-authors 28
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 15
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
William C Jackson
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 48
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 11
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 1
Nikhil T Sebastian
Emory University
Career Start Year 2011
Number of shared co-authors 1
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Career Start Year 2011
Number of shared co-authors 26
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 15
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 2
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 13
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 23
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 5
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 2
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 4
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 4
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 6
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 6
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 38
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 5
Constantine A Mantz
University of Chicago
Career Start Year 1997
Number of shared co-authors 28
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 3
Charles R Thomas
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 16
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 9

Collaborators

Erqi L Pollom
Stanford University
Co-authored papers 13
Amar U Kishan
University of California los angeles
Co-authored papers 13
Michael L Steinberg
University of California los angeles
Co-authored papers 10
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 8
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 8
Ting Martin Ma
University of Washington
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 7
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 7
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Marco F Ramoni
Children's Hospital Informatics Program, Harvard Medical School
Co-authored papers 4
Paul C Boutros
University of California los angeles
Co-authored papers 4
Beth M Beadle
Stanford University
Co-authored papers 4
Thomas M Pisansky
Mayo Clinic
Co-authored papers 4
Robert T Dess
University of Michigan ann arbor
Co-authored papers 4
Gil Alterovitz
Brigham and Women's Hospital
Co-authored papers 4
Avinash Pilar
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 3
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Co-authored papers 3
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 3
Brian J Davis
Mayo Clinic
Co-authored papers 3
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 3
Eyad Abu-Isa
Ascension Providence Hospital
Co-authored papers 3
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 3
Curtiland Deville
Johns Hopkins University
Co-authored papers 3
Allison Steigler
University of Newcastle
Co-authored papers 3
James W Denham
University of Newcastle
Co-authored papers 3
David Jeffrey Demanes
University of California los angeles
Co-authored papers 3
Trude B Wedde
Oslo University Hospital
Co-authored papers 3
Chandana A Reddy
Cleveland Clinic
Co-authored papers 3
Jay P Ciezki
Cleveland Clinic
Co-authored papers 3
Release 1.2